| Market Cap | ₹13,886Cr |
| ROE | 17.73% |
| P/E Ratio(TTM) | 42.93 |
| EPS(TTM) | 30.92 |
| P/B Ratio | 7.60 |
| Dividend Yield | 0.66% |
| Industry P/E | 33.31 |
| Book Value | 174.68 |
| Debt to Equity | 0.00 |
| Face Value | 1 |
| Parent Organisation | Concord Biotech |
| Managing Director | Mr. Ankur Vaid |
| NSE Symbol | CONCORDBIO |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.42 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 31.89 | ||
| Wockhardt | NA (0.00%) | -459.97 | ||
| Cohance Lifesciences | NA (0.00%) | 65.93 |